Viemed Healthcare (VMD) Change in Receivables (2018 - 2026)
Viemed Healthcare (VMD) posted Change in Receivables of $5.6 million for Q1 2026, up 405.96% on a QoQ basis from -$1.8 million in Q4 2025, and up 197.82% year-over-year from $1.9 million in Q1 2025.
Viemed Healthcare (VMD) Change in Receivables (2018 - 2026) Analysis & Trends
Viemed Healthcare's Change in Receivables history runs 9 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- Quarterly Change in Receivables rose 197.82% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 32.83% YoY) and the FY2025 annual result came in at -$1.2 million, down 119.07% from the prior year.
- Change in Receivables was $5.6 million for Q1 2026 at Viemed Healthcare, up from -$1.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $6.0 million in Q1 2024 and bottomed at -$2.8 million in Q2 2022.
- A 5-year average of $830705.9 and a median of $397000.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables jumped 598.64% — and 2025, when it plunged 7966.67%.
- Viemed Healthcare's Change in Receivables stood at $397000.0 in 2022, then soared by 32.24% to $525000.0 in 2023, then plunged by 507.62% to -$2.1 million in 2024, then climbed by 14.58% to -$1.8 million in 2025, then soared by 405.96% to $5.6 million in 2026.
- Business Quant data shows VMD's Change in Receivables at $5.6 million in Q1 2026, -$1.8 million in Q4 2025, and -$968000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 5.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.59 Mn |
| Mar 31, 2026 | 5.59 Mn |
| Dec 31, 2025 | -1.83 Mn |
| Dec 31, 2025 | -1.83 Mn |
| Sep 30, 2025 | -968,000.00 |
| Sep 30, 2025 | -968,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Mar 31, 2025 | 1.88 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | -2.14 Mn |
| Dec 31, 2024 | -2.14 Mn |
| Sep 30, 2024 | -12,000.00 |
| Sep 30, 2024 | -12,000.00 |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 525,000.00 |
| Dec 31, 2023 | 525,000.00 |